(Q36621918)

English

Treatment of advanced medullary thyroid cancer with an alternating combination of doxorubicin-streptozocin and 5 FU-dacarbazine. Groupe d'Etude des Tumeurs à Calcitonine (GETC).

scientific article published on September 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Treatment of advanced medullary thyroid cancer with an alternating combination of doxorubicin-streptozocin and 5 FU-dacarbazine. Groupe d'Etude des Tumeurs à Calcitonine (GETC). (English)

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

1 reference

based on heuristic

inferred from title

author name string

Nocera M

1

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Baudin E

2

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Pellegriti G

3

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Cailleux AF

4

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Mechelany-Corone C

5

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Schlumberger M

6

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

language of work or name

0 references

publication date

1 September 2000

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

British Journal of Cancer

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

83

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

6

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

715-718

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

https://scigraph.springernature.com/pub.10.1054/bjoc.2000.1314

0 references

Medullary thyroid cancer: analyses of survival and prognostic factors and the role of radiation therapy in local control

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363532

30 September 2017

The management of patients with advanced carcinoid tumors and islet cell carcinomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363532

30 September 2017

Chemotherapy with dacarbazine and 5-fluorouracil in advanced medullary thyroid cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363532

30 September 2017

Treatment of advanced medullary thyroid cancer with an alternating combination of 5 FU-streptozocin and 5 FU-dacarbazine. The Groupe d'Etude des Tumeurs a Calcitonine (GETC)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363532

30 September 2017

Reporting results of cancer treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363532

30 September 2017

Long-term course of patients with persistent hypercalcitoninemia after apparent curative primary surgery for medullary thyroid carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363532

30 September 2017

Medullary thyroid carcinoma: genetic advances, treatment recommendations, and the approach to the patient with persistent hypercalcitoninemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363532

28 June 2018

External radiotherapy in thyroid cancers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363532

28 June 2018

A randomized trial of doxorubicin versus doxorubicin plus cisplatin in patients with advanced thyroid carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363532

28 June 2018

A phase II trial of streptozotocin and adriamycin in advanced APUD tumors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363532

28 June 2018

Intrinsic drug resistance in a human medullary thyroid carcinoma cell line: association with overexpression of mdrl gene and low proliferation fraction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363532

28 June 2018

Phase II evaluation of doxorubicin plus cisplatin in advanced thyroid cancer: a Southeastern Cancer Study Group Trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/10952773

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapy for thyroid cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/10952773

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metastatic medullary thyroid carcinoma. Complete response to combination chemotherapy with dacarbazine and 5-fluorouracil

1 reference

https://pubmed.ncbi.nlm.nih.gov/10952773

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapy in metastatic nonanaplastic thyroid cancer: experience at the Institut Gustave-Roussy

1 reference

https://pubmed.ncbi.nlm.nih.gov/10952773

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined chemotherapy with bleomycin, adriamycin, and platinum in advanced thyroid cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/10952773

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of advanced medullary thyroid carcinoma with a combination of cyclophosphamide, vincristine, and dacarbazine

1 reference

https://pubmed.ncbi.nlm.nih.gov/10952773

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase II trial of dacarbazine, fluorouracil and epirubicin in patients with neuroendocrine tumours. A study by the Italian Trials in Medical Oncology (I.T.M.O.) Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/10952773

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Medullary thyroid cancer: the role of radiotherapy in local control

1 reference

https://pubmed.ncbi.nlm.nih.gov/10952773

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Medullary carcinoma of the thyroid. A study of the clinical features and prognostic factors in 161 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/10952773

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1054/BJOC.2000.1314

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36621918&oldid=1528560229"